Evidence map›Paper›PMID 39219152›Full record

ArticleBritish journal of haematology2024

Pericardial events associated with ibrutinib-based therapies for chronic lymphocytic leukaemia in two landmark trials.

Bita Fakhri, Victoria Wang, Gabriela Perez-Burbano, Anna Wall, Sumithra Mandrekar, Sameer A Parikh, Jennifer Woyach, Tait Shanafelt

Abstract readLetter
In one paragraph

Article in British journal of haematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bita FakhriStanford University School of Medicine, Palo Alto, California, USA.ORCID https://orcid.org/0000-0002-2124-7243
Victoria WangDana-Farber Cancer Institute, Boston, Massachusetts, USA.
Gabriela Perez-BurbanoMayo Clinic, Rochester, Minnesota, USA.
Anna WallMayo Clinic, Rochester, Minnesota, USA.
Sumithra MandrekarMayo Clinic, Jacksonville, Florida, USA.
Sameer A ParikhMayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-3221-7314
Jennifer WoyachThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0002-3403-9144
Tait ShanafeltStanford University School of Medicine, Palo Alto, California, USA.

Funding

Member Site CoreU10CA180821 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Evanthia Galanis · 2014 to 2026
$177.3M
Project-006U10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer · 2014 to 2026
$167.6M
Statistics CoreU10CA180882 · NCI · MAYO CLINIC ROCHESTER · PI Sumithra Jay Mandrekar · 2014 to 2026
$115.0M
Statistics CoreU10CA180794 · NCI · DANA-FARBER CANCER INST · PI PAUL J CATALANO, CONSTANTINE A. GATSONIS · 2014 to 2026
$111.2M
OSU as a Network Lead Academic Participating Site for the NCI NCTNUG1CA233331 · NCI · OHIO STATE UNIVERSITY · PI John L. Hays, Dwight H. Owen · 2019 to 2026
$8.9M
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer CareUG1CA233180 · NCI · DANA-FARBER CANCER INST · PI Harold John Burstein · 2019 to 2026
$8.6M
NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1 (funded extension)UG1CA232760 · NCI · MAYO CLINIC ROCHESTER · PI Judy Caroline Boughey, Aaron Scott Mansfield · 2019 to 2026
$8.5M
NCI NIH HHS U10 CA180794NCI NIH HHS U10 CA180820NCI NIH HHS U10 CA180821NCI NIH HHS U10 CA180882NCI NIH HHS UG1 CA232760NCI NIH HHS UG1 CA233180NCI NIH HHS UG1 CA233331NIH HHS U10CA180820NIH HHS U10CA180821NIH HHS U10CA180882NIH HHS UG1CA232760NIH HHS UG1CA233180NIH HHS UG1CA233331
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39219152
PMCPMC11486548

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.